GSK Investigational Site is a clinical research site located in Greensboro, North Carolina, United States 27405.
Crixeo Clinical Trials Trust Score: 29/100 (FAILING). This profile has not yet been claimed by the site owner.
GSK Investigational Site has participated in 71 clinical trials with 5 currently active.
Therapeutic areas: Influenza, Human, Heart Failure, Congestive and Microalbuminuria, Irritable Bowel Syndrome (IBS).
Sponsors: GlaxoSmithKline, Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA), XenoPort, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in North Carolina · View every site in Greensboro
Trust Score: 29/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
GSK Investigational Site has a Crixeo Trust Score of 29/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
GSK Investigational Site has 71 clinical trials on record, with 5 currently active. Their work covers Influenza, Human, Heart Failure, Congestive and Microalbuminuria, Irritable Bowel Syndrome (IBS).
GSK Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.